Thompson, Sarah
Pang, Chong Yun
Sepuru, Krishna Mohan
Cambier, Seppe
Hellyer, Thomas P.
Scott, Jonathan
Simpson, A. John
Proost, Paul
Kirby, John A.
Rajarathnam, Krishna
Sheerin, Neil S.
Ali, Simi http://orcid.org/0000-0002-4122-5631
Funding for this research was provided by:
NIH (NIH R21AI160613)
Kidney Research UK (KS_IN_009_20190919)
British Heart Foundation (FS/15/19/31327)
Engineering and Physical Sciences Research Council (MosMed CDT)
FWO-Vlaanderen PhD fellowship (C16/17/010)
Norther Accelerator Award
Article History
Received: 16 September 2022
Revised: 24 November 2022
Accepted: 9 December 2022
First Online: 9 January 2023
Declarations
:
: The authors declare that they have no competing interests.
: Animal work was approved by the Home Office UK, and carried out under Project Licence number 66/4497, protocol number 19b2/19b4. Patient samples. BAL samples from patients with suspected-VAP and healthy controls were collected as part of study approved by a Research Ethics committee (11/NE/0242) [CitationRef removed].
: Informed consent was obtained from all individual participants included in the study.
: Data are anonymized and not presented is identifiable form.